Related Experiment Video

Updated: Jun 16, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

MicroRNA-145 targets YES and STAT1 in colon cancer cells

Lea H Gregersen1, Anders B Jacobsen, Lisa B Frankel

  • 1Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Copenhagen, Denmark.

Plos One
|January 26, 2010
PubMed
Abstract

Insights

This study identifies new direct targets of microRNA-145 (miR-145) in colon cancer. These findings enhance understanding of miR-145's tumor-suppressive role in this disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are crucial gene regulators implicated in cancer development.
  • miR-145 is frequently downregulated in various cancers, but its specific targets in colon cancer are not well-defined.

Purpose of the Study:

  • To identify and validate novel direct targets of miR-145 in colon cancer.
  • To elucidate the mechanistic role of miR-145 in colon tumorigenesis.

Main Methods:

  • Utilized a microarray-based approach to discover miR-145 targets.
  • Performed seed site enrichment and unbiased word analyses on 3'-untranslated regions (UTRs).
  • Validated direct targeting of YES and STAT1 using experimental methods.

Main Results:

  • Identified significant enrichment of miR-145 binding sites in downregulated transcripts.
  • Gene Ontology analysis revealed overrepresentation in cancer-related pathways like cell death and proliferation.
  • Confirmed YES and STAT1 as direct miR-145 targets, among other potential cancer-relevant genes.

Conclusions:

  • This research identifies and validates new direct targets of miR-145 relevant to colon cancer.
  • Provides crucial mechanistic insights into the tumor-suppressive functions of miR-145.

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...